Notch signaling in T-cell acute lymphoblastic leukemia

Future Oncology

Volumn 1, Issue 4, 2005, Pages 511-519

  Weng, Andrew P ^a   Lau, Arthur ^a  

^a BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

secretase? secretase inhibitor; chemotherapy; leukemia; mutation; Notch; presenilin; signal transduction; T cell acute lymphoblastic leukemia

Indexed keywords

NOTCH RECEPTOR;

ANIMAL; CHILD; GENETICS; HUMAN; MUTATION; PHYSIOLOGY; REVIEW; T CELL LEUKEMIA;

ANIMALS; CHILD; HUMANS; LEUKEMIA, T-CELL, ACUTE; MUTATION; RECEPTORS, NOTCH;

EID: 27944475340     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.1.4.511     Document Type: Review

References (118)

1. Uckun FM, Sensel MG, Sun L et al.: Biology and treatment of childhood Tlineage acute lymphoblastic leukaemia. Blood 91(3), 735-746 (1998
2. Faderl S, Kantarjian HM, Talpaz M, Estrov Z: Clinical significance of cytogenetic abnormalities in adult acute lymphoblastic leukaemia. Blood 91(11), 3995-4019 (1998
3. Shuster JJ, Falletta JM, Pullen DJ et al.: Prognostic factors in childhood T cell acute lymphoblastic leukaemia: a Pediatric Oncology Group study. Blood 75(1), 166-173 (1990
4. Goldberg JM, Silverman LB, Levy DE et al.: Childhood T cell acute lymphoblastic leukaemia: the Dana-Farber Cancer Institute acute lymphoblastic leukaemia consortium experience. J. Clin. Oncol. 21(19), 3616-3622 (2003
5. Harrison CJ, Foroni L. Cytogenetics and molecular genetics of acute lymphoblastic leukaemia. Rev. Clin. Exp. Hematol. 6(2), 91-113; discussion 200-112 (2002
6. Asnafi V, Beldjord K, Boulanger E et al.: Analysis of TCR, pT α, and RAG-1 in T-acute lymphoblastic leukaemias improves understanding of early human T-lymphoid lineage commitment. Blood 101(7), 2693-2703 (2003
7. Johansson B, Mertens F, Mitelman F: Clinical and biological importance of cytogenetic abnormalities in childhood and adult acute lymphoblastic leukaemia. Ann. Med. 36(7), 492-503 (2004
8. Ferrando AA, Neuberg DS, Staunton J et al.: Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukaemia. Cancer Cell 1(1), 75-87 (2002
9. Hasserjian RP, Aster JC, Davi F, Weinberg DS, Sklar J: Modulated expression of Notch1 during thymocyte development. Blood 88(3), 970-976 (1996
10. Screpanti I, Bellavia D, Campese AF, Frati L, Gulino A: Notch, a unifying target in T cell acute lymphoblastic leukaemia? Trends Mol. Med. 9(1), 30-35 (2003
11. Ye Y, Lukinova N, Fortini ME: Neurogenic phenotypes and altered Notch processing in Drosophila presenilin mutants. Nature 398, 525-529 (1999
12. Song W, Nadeau P, Yuan M et al.: Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc. Natl Acad. Sci. USA 96(12), 6959-6963 (1999
13. Struhl G, Grenwald I: Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398, 522-525 (1999
14. De Strooper B, Annaert W, Cupers P et al.: A presenilin-1-dependent α-secretase-like protease mediates release of Notch intracellular domain. Nature 398, 518-522 (1999
15. Fortini ME, Artavanis-Tsakonas S: The suppressor of hairless protein participates in notch receptor signalling. Cell 79(2), 273-282 (1994
16. Schweisguth F, Posakony JW: Suppressor of Hairless, the Drosophila homolog of the mouse recombination signal-binding protein gene, controls sensory organ cell fates. Cell 69(7), 1199-1212 (1992
17. Jarriault S, Brou C, Logeat F et al.: Signalling downstream of activated mammalian Notch. Nature 377(6547), 355-358 (1995
18. Kao HY, Ordentlich P, Koyano-Nakagawa N et al.: A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 12(15), 2269-2277 (1998
19. Hsieh JJ, Zhou S, Chen L, Young DB, Hayward SD: CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex. Proc. Natl Acad. Sci. USA 96(1), 23-28 (1999
20. Wu L, Aster JC, Blacklow SC et al.: MAML1, a human homologue of Drosophila mastermind, is a transcriptional co-activator for NOTCH receptors. Nature Genet. 26(4), 484-489 (2000
21. Kitagawa M, Oyama T, Kawashima T et al.: A human protein with sequence similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters. Mol. Cell. Biol. 21(13), 4337-4346 (2001
22. Wu L, Sun T, Kobayashi K, Gao P, Griffin JD: Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors. Mol. Cell. Biol. 22(21), 7688-7700 (2002
23. Kurooka H, Honjo T: Functional interaction between the mouse Notch1 intracellular region and histone acetyltransferases PCAF and GCN5. J. Biol. Chem. 275, 17211-17220 (2000
24. Fryer CJ, Lamar E, Turbachova I, Kintner C, Jones KA: Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. Genes Dev. 16(11), 1397-1411 (2002
25. Wallberg AE, Pedersen K, Lendahl U, Roeder RG: p300 and PCAF act cooperatively to mediate transcriptional activation from chromatin templates by notch intracellular domains in vitro. Mol. Cell. Biol. 22(22), 7812-7819 (2002
26. Fryer CJ, White JB, Jones KA: Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol. Cell 16(4), 509-520 (2004
27. Nam Y, Weng AP, Aster JC, Blacklow SC: Structural requirements for assembly of the CSL:intracellular Notch1:Mastermindlike 1 transcriptional activation complex. J. Biol. Chem. 278(23), 21232-21239 (2003
28. Ellisen LW, Bird J, West DC et al.: TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66(4), 649-661 (1991
29. Pear WS, Aster JC, Scott ML et al.: Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J. Exp. Med. 183(5), 2283-2291 (1996
30. Aster JC, Xu L, Karnell FG et al.: Essential roles for ankyrin repeat and transactivation domains in induction of T cell leukaemia by Notch1. Mol. Cell. Biol. 20(20), 7505-7515 (2000
31. Weng AP, Nam Y, Wolfe MS et al.: Growth suppression of pre-T acute lymphoblastic leukaemia cells by inhibition of notch signalling. Mol. Cell. Biol. 23(2), 655-664 (2003
32. Weng AP, Ferrando AA, Lee W et al.: Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukaemia. Science 306(5694), 269-271 (2004
33. Sanchez-Irizarry C, Carpenter AC, Weng AP et al.: Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol. Cell. Biol. 24(21), 9265-9273 (2004
34. Rogers S, Wells R, Rechsteiner M: Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364-368 (1986
35. Pear WS, Radtke F: Notch signalling in lymphopoiesis. Semin. Immunol. 15(2), 69-79 (2003
36. Izon DJ, Punt JA, Xu L et al.: Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. Immunity 14(3), 253-264 (2001
37. Allman D, Karnell FG, Punt JA et al.: Separation of Notch1 promoted lineage commitment and expansion/transformation in developing T cells. J. Exp. Med. 194(1), 99-106 (2001
38. Ordentlich P, Lin A, Shen CP et al.: Notch inhibition of E47 supports the existence of a novel signalling pathway. Mol. Cell. Biol. 18(4), 2230-2239 (1998
39. Nie L, Xu M, Vladimirova A, Sun XH: Notch-induced E2A ubiquitination and degradation are controlled by MAPK activities. EMBO J. 22(21), 5780-5792 (2003
40. Talora C, Campese AF, Bellavia D et al.: Pre-TCR-triggered ERK signalling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep. 4(11), 1067-1072 (2003
41. Bain G, Engel I, Robanus Maandag EC et al.: E2A deficiency leads to abnormalities in α/βT cell development and to rapid development of T cell lymphomas. Mol. Cell. Biol. 17(8), 4782-4791 (1997
42. ONeil J, Shank J, Cusson N, Murre C, Kelliher M: TAL1/SCL induces leukaemia by inhibiting the transcriptional activity of E47/HEB. Cancer Cell 5(6), 587-596 (2004
43. Lehar SM, Dooley J, Farr AG, Bevan MJ: Notch ligands Delta1 and Jagged1 transmit distinct signals to T-cell precursors. Blood 105(4), 1440-1447 (2005
44. Balciunaite G, Ceredig R, Fehling HJ, Zuniga-Pflucker JC, Rolink AG: The role of Notch and IL-7 signalling in early thymocyte proliferation and differentiation. Eur. J. Immunol. 35(4), 1292-1300 (2005
45. Sade H, Krishna S, Sarin A: The antiapoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signalling in T cells. J. Biol. Chem. 279(4), 2937-2944 (2004
46. Bellavia D, Campese AF, Alesse E et al.: Constitutive activation of NF-κB and T cell leukaemia/lymphoma in Notch3 transgenic mice. EMBO J. 19(13), 3337-3348 (2000
47. Jehn BM, Bielke W, Pear WS, Osborne BA: Cutting edge: protective effects of Notch-1 on TCR-induced apoptosis. J. Immunol. 162(2), 635-638 (1999
48. Feldman BJ, Hampton T, Cleary ML: A carboxy-terminal deletion mutant of Notch1 accelerates lymphoid oncogenesis in E2APBX1 transgenic mice. Blood 96(5), 1906-1913 (2000
49. Girand L, Hanna Z, Beaulieu N et al.: Frequent proviral insertional mutagenesis of NOTCH1 in thymomas of MMTVD/myc transgenic mice suggests a collaboration of c-myc and NOTCH1 for oncogenesis. Genes Dev. 10, 1930-1944 (1996
50. Hoemann CD, Beaulieu N, Girard L, Rebai N, Jolicoeur P: Two distinct Notch1 mutant alleles are involved in the induction of T-cell leukaemia in c-myc transgenic mice. Mol. Cell. Biol. 20(11), 3831-3842 (2000
51. Beverly LJ, Capobianco AJ: Perturbation of Ikaros isoform selection by MLV integration is a cooperative event in Notch(IC)-induced T cell leukemogenesis. Cancer Cell 3(6), 551-564 (2003
52. Harrison T, Churcher I, Beher D: β-secretase as a target for drug intervention in Alzheimers disease. Curr. Opin. Drug Discov. Devel. 7(5), 709-719 (2004
53. Sisodia SS, Kim SH, Thinakaran G: Function and dysfunction of the presenilins. Am. J. Hum. Genet. 65(1), 7-12 (1999
54. Wolfe MS, Haass C: The role of presenilins in β-secretase activity. J. Biol. Chem. 276(8), 5413-5416 (2001
55. Xu T, Artavanis-Tsakonas S: Deltex, a locus interacting with the neurogenic genes, Notch, Delta and mastermind in Drosophila melanogaster. Genetics 126(3), 665-677 (1990
56. Gorman MJ, Girton JR: A genetic analysis of Deltex and its interaction with the Notch locus in Drosophila melanogaster. Genetics 131(1), 99-112 (1992
57. Izon DJ, Aster JC, He Y et al.: Deltex1 redirects lymphoid progenitors to the B-cell lineage by antagonizing Notch1. Immunity 16(2), 231-243 (2002
58. Radtke F, Wilson A, Stark G et al.: Deficient T-cell fate specification in mice with an induced inactivation of Notch1. Immunity 10(5), 547-558 (1999
59. Pui JC, Allman D, Xu L et al.: Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11(3), 299-308 (1999
60. Matsuno K, Diederich RJ, Go MJ, Blaumueller CM, Artavanis-Tsakonas S: Deltex acts as a positive regulator of Notch signalling through interactions with the Notch ankyrin repeats. Development 121(8), 2633-2644 (1995
61. Matsuno K, Eastman D, Mitsiades T et al.: Human Deltex is a conserved regulator of Notch signalling. Immunity 19(1), 74-78 (1998
62. Yamamoto N, Yamamoto S, Inagaki F et al.: Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. J. Biol. Chem. 276(48), 45031-45040 (2001
63. Diederich RJ, Matsuno K, Hing H, Artavanis-Tsakonas S: Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in the Notch signalling pathway. Development 120(3), 473-481 (1994
64. Busseau I, Diederich RJ, Xu T, Artavanis-Tsakonas S: A member of the Notch group of interacting loci, deltex encodes a cytoplasmic basic protein. Genetics 136(2), 585-596 (1994
65. Takeyama K, Aguiar RC, Gu L et al.: The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitinprotein isopeptide ligase activity. J. Biol. Chem. 278(24), 21930-21937 (2003
66. Cornell M, Evans DA, Mann R et al.: The Drosophila melanogaster suppressor of deltex gene, a regulator of the Notch receptor signalling pathway, is an E3 class ubiquitin ligase. Genetics 152(2), 567-576 (1999
67. Qiu L, Joazeiro C, Fang N et al.: Recognition and ubiquitination of Notch by Itch, a hect-type E3 ubiquitin ligase. J. Biol. Chem. 275(46), 35734-35737 (2000
68. McGill MA, McGlade CJ: Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J. Biol. Chem. 278(25), 23196-23203 (2003
69. Jehn BM, Dittert I, Beyer S, von der Mark K, Bielke W: c-Cbl binding and ubiquitindependent lysosomal degradation of membrane-associated Notch1. J. Biol. Chem. 277(10), 8033-8040 (2002
70. Wu G, Lyapina S, Das I et al.: SEL-10 is an inhibitor of Notch signalling that targets Notch for ubiquitin-mediated protein degradation. Mol. Cell. Biol. 21(21), 7403-7415 (2001
71. Oberg C, Li J, Pauley A et al.: The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian SEL-10 homolog. J. Biol. Chem. 276(38), 35847-35853 (2001
72. Gupta-Rossi N, Le Bail O, Gonen H et al.: Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J. Biol. Chem. 276(37), 34371-34378 (2001
73. Maillard I, Weng AP, Carpenter AC et al.: Mastermind critically regulates Notchmediated lymphoid cell fate decisions. Blood 104(6), 1696-1702 (2004
74. Matsuno K, Go MJ, Sun X, Eastman DS, Artavanis-Tsakonas S: Suppressor of Hairless-independent events in Notch signalling imply novel pathway elements. Development 124(21), 4265-4273 (1997
75. Wang S, Younger-Shepherd S, Jan LY, Jan YN: Only a subset of the binary cell fate decisions mediated by Numb/Notch signalling in Drosophila sensory organ lineage requires Suppressor of Hairless. Development 124(22), 4435-4446 (1997
76. Shawber C, Nofziger D, Hsieh JJ et al.: Notch signalling inhibits muscle cell differentiation through a CBF1-independent pathway. Development 122(12), 3765-3773 (1996
77. Nofziger D, Miyamoto A, Lyons KM, Weinmaster G: Notch signalling imposes two distinct blocks in the differentiation of C2C12 myoblasts. Development 126(8), 1689-1702 (1999
78. Jeffries S, Capobianco AJ: Neoplastic transformation by Notch requires nuclear localization. Mol. Cell. Biol. 20(11), 3928-3941 (2000
79. MacKenzie F, Duriez P, Wong F, Noseda M, Karsan A: Notch4 inhibits endothelial apoptosis via RBP-J-dependent and -independent pathways. J. Biol. Chem. 279(12), 11657-11663 (2004
80. Maier MM, Gessler M: Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem. Biophys. Res. Commun. 275(2), 652-660 (2000
81. Deftos ML, He YW, Ojala EW, Bevan MJ: Correlating Notch signalling with thymocyte maturation. Immunity 9(6), 777-786 (1998
82. Deftos ML, Huang E, Ojala EW, Forbush KA, Bevan MJ: Notch1 signalling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13(1), 73-84 (2000
83. Doerfler P, Shearman MS, Perlmutter RM: Presenilin-dependent β-secretase activity modulates thymocyte development. Proc. Natl Acad. Sci. USA 98(16), 9312-9317 (2001
84. Searfoss GH, Jordan WH, Calligaro DO et al.: Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional β-secretase inhibitor. J. Biol. Chem. 278(46), 46107-46116 (2003
85. Milano J, McKay J, Dagenais C et al.: Modulation of notch processing by β-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation. Toxicol. Sci. 82(1), 341-358 (2004
86. Miyamoto Y, Maitra A, Ghosh B et al.: Notch mediates TGFβ-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3(6), 565-576 (2003
87. Talora C, Sgroi DC, Crum CP, Dotto GP: Specific down-modulation of Notch1 signalling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation. Genes Dev. 16(17), 2252-2263 (2002
88. Weijzen S, Zlobin A, Braid M, Miele L, Kast WM: HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation. J. Cell. Physiol. 194(3), 356-362 (2003
89. Nair P, Somasundaram K, Krishna S: Activated Notch1 inhibits p53-induced apoptosis and sustains transformation by human papillomavirus Type 16 E6 and E7 oncogenes through a PI3K-PKB/Aktdependent pathway. J. Virol. 77(12), 7106-7112 (2003
90. Santagata S, Demichelis F, Riva A et al.: JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res. 64(19), 6854-6857 (2004
91. Jundt F, Anagnostopoulos I, Forster R et al.: Activated Notch1 signalling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma. Blood 99(9), 3398-3403 (2002
92. Jundt F, Probsting KS, Anagnostopoulos I et al.: Jagged1-induced Notch signalling drives proliferation of multiple myeloma cells. Blood 103(9), 3511-3515 (2004
93. Houde C, Li Y, Song L et al.: Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines. Blood 104(12), 3697-3704 (2004
94. Hubmann R, Schwarzmeier JD, Shehata M et al.: Notch2 is involved in the overexpression of CD23 in B cell chronic lymphocytic leukaemia. Blood 99(10), 3742-3747 (2002
95. Hoek K, Rimm DL, Williams KR et al.: Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res. 64(15), 5270-5282 (2004
96. Mailhos C, Modlich U, Lewis J et al.: 4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 69(2-3), 135-144 (2001
97. Sullivan DC, Bicknell R: New molecular pathways in angiogenesis. Br. J. Cancer 89(2), 228-231 (2003
98. Varnum-Finney B, Purton LE, Yu M et al.: The Notch ligand, Jagged-1, influences the development of primitive hematopoietic precursor cells. Blood 91(11), 4084-4091 (1998
99. Varnum-Finney B, Xu L, Brashem-Stein C et al.: Pluripotent, cytokine-dependent, hematopoietic stem cells are immortalized by constitutive notch1 signalling. Nature Med. 6(11), 1278-1281 (2000
100. Felli MP, Maroder M, Mitsiadis TA et al.: Expression pattern of Notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligandreceptor interactions in intrathymic T cell development [In Process Citation]. Int. Immunol. 11(7), 1017-1025 (1999
101. Rohn J, Lauring A, Linenberger M, Overbaugh J: Transduction of Notch2 in feline leukaemia virus-induced thymic lymphoma. J. Virol. 70(11), 8071-8080 (1996
102. Aster JC, Weng AP, Blacklow SC et al.: Activated Notch4 induces T lymphocyte development without causing T cell transformation. Blood 102(11) [Abstract 2158] (2003
103. Vercauteren SM, Sutherland HJ: Constitutively active Notch4 promotes early human hematopoietic progenitor cell maintenance while inhibiting differentiation and causes lymphoid abnormalities in vivo. Blood 104(8), 2315-2322 (2004
104. Brown L, Cheng JT, Chen Q et al.: Sitespecific recombination of the tal-1 gene is a common occurrence in human T-cell leukaemia. EMBO J. 9(10), 3343-3351 (1990
105. Finger LR, Kagan J, Christopher G et al.: Involvement of the TCL5 gene on human chromosome 1 in T cell leukaemia and melanoma. Proc. Natl Acad. Sci. USA 86(13), 5039-5043 (1989
106. Porcher C, Swat W, Rockwell K et al.: The T-cell leukaemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86(1), 47-57 (1996
107. Hatano M, Roberts CW, Minden M, Crist WM, Korsmeyer SJ. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T-cell leukaemia. Science 253(5015), 79-82 (1991
108. Kennedy MA, Gonzalez-Sarmiento R, Kees UR et al.: HOX11, a homeobox-containing T cell oncogene on human chromosome 10q24. Proc. Natl Acad. Sci. USA 88(20), 8900-8904 (1991
109. Dear TN, Colledge WH, Carlton MB et al.: The Hox11 gene is essential for cell survival during spleen development. Development 121(9), 2909-2915 (1995
110. Bernard OA, Busson-LeConiat M, Ballerini P et al.: A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukaemia. Leukaemia 15(10), 1495-1504 (2001
111. Su XY, Busson M, Della Valle V et al.: Various types of rearrangements target TLX3 locus in T-cell acute lymphoblastic leukaemia. Genes Chrom. Cancer 41(3), 243-249 (2004
112. Baer R: TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T-cell acute leukaemia. Semin. Cancer Biol. 4(6), 341-347 (1993
113. Asnafi V, Radford-Weiss I, Dastugue N et al.: CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRα/βlineage. Blood 102(3), 1000-1006 (2003
114. Carlson KM, Vignon C, Bohlander S et al.: Identification and molecular characterization of CALM/AF10 fusion products in T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia. Leukaemia 14(1), 100-104 (2000
115. Burnett RC, David JC, Harden AM et al.: The LCK gene is involved in the t(1;7)(p34;q34) in the T-cell acute lymphoblastic leukaemia derived cell line, HSB-2. Genes Chrom. Cancer 3, 461-467 (1991
116. Burnett RC, Thirman MJ, Rowley JD, Diaz MO: Molecular analysis of the T-cell acute lymphoblastic leukaemia-associated t(1;7)(p34;q34) that fuses LCK and TCRB. Blood 84(4), 1232-1236 (1994
117. Erikson J, Finger L, Sun L et al.: Deregulation of c-myc by translocation of the β-locus of the T-cell receptor in T-cell leukaemias. Science 232(4752), 884-886 (1986
118. Shima-Rich EA, Harden AM, McKeithan TW, Rowley JD, Diaz MO: Molecular analysis of the t(8;14)(q24;q11) chromosomal breakpoint junctions in the T cell leukaemia line MOLT-16. Genes Chrom. Cancer 20(4), 363-371 (1997